TCM product approved for sale in Singapore
By Zhang Yu in Shijiazhuang |
chinadaily.com.cn |
Updated: 2020-05-07 15:56
Share
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Snapshots of Chinese space station passing in front of sun
- China accelerates nuclear fusion engineering, targeting power generation demonstration by 2030
- Xinjiang leads China in cross-border rail traffic, central Asian connectivity in 2025
- Astronauts say training helped ensure safe return
- FAST reveals insights into cosmic signals
- Year's first private rocket mission takes off
